Ladenburg Thalmann Financial Services’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,866
| Closed | -$54K | – | 5692 |
|
|
2019
Q3 | $54K | Sell |
2,866
-45
| -2% | -$515 | ﹤0.01% | 3404 |
|
|
2019
Q2 | $34K | Sell |
2,911
-6
| -0.2% | -$73 | ﹤0.01% | 3734 |
|
|
2019
Q1 | $40K | Hold |
2,917
| – | – | ﹤0.01% | 3565 |
|
|
2018
Q4 | $30K | Sell |
2,917
-104
| -3% | -$1.33K | ﹤0.01% | 3633 |
|
|
2018
Q3 | $50K | Sell |
3,021
-409
| -12% | -$7.39K | ﹤0.01% | 3318 |
|
|
2018
Q2 | $44K | Hold |
3,430
| – | – | ﹤0.01% | 3353 |
|
|
2018
Q1 | $44K | Sell |
3,430
-206
| -6% | -$2.98K | ﹤0.01% | 3353 |
|
|
2017
Q4 | $41K | Buy |
3,636
+858
| +31% | +$9.58K | ﹤0.01% | 3365 |
|
|
2017
Q3 | $33K | Buy |
2,778
+855
| +44% | +$8.91K | ﹤0.01% | 3385 |
|
|
2017
Q2 | $22K | Buy |
1,923
+1,700
| +762% | +$31.4K | ﹤0.01% | 3565 |
|
|
2017
Q1 | $4K | Sell |
223
-150
| -40% | -$3.32K | ﹤0.01% | 4429 |
|
|
2016
Q4 | $7K | Hold |
373
| – | – | ﹤0.01% | 4100 |
|
|
2016
Q3 | $12K | Hold |
373
| – | – | ﹤0.01% | 3733 |
|
|
2016
Q2 | $10K | Buy |
373
+150
| +67% | +$4.06K | ﹤0.01% | 3799 |
|
|
2016
Q1 | $6K | Sell |
223
-26
| -10% | -$602 | ﹤0.01% | 4022 |
|
|
2015
Q4 | $9K | Hold |
249
| – | – | ﹤0.01% | 3758 |
|
|
2015
Q3 | $9K | Sell |
249
-800
| -76% | -$34K | ﹤0.01% | 3625 |
|
|
2015
Q2 | $56K | Buy |
1,049
+49
| +5% | +$1.78K | ﹤0.01% | 2513 |
|
|
2015
Q1 | $29K | Sell |
1,000
-6,750
| -87% | -$185K | ﹤0.01% | 2955 |
|
|
2014
Q4 | $225K | Buy |
7,750
+6,900
| +812% | +$124K | 0.01% | 1344 |
|
|
2014
Q3 | $11K | Sell |
850
-5,750
| -87% | -$86.9K | ﹤0.01% | 3071 |
|
|
2014
Q2 | $132K | Buy |
+6,600
| New | +$92.9K | ﹤0.01% | 1431 |
|
Ladenburg Thalmann Financial Services's ALDR Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 2,866 shares — an estimated $54K sold.
Ladenburg Thalmann Financial Services first reported a position in ALDR in Q2 2014 and held it in 22 quarters. The position peaked at $225K in Q4 2014. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Ladenburg Thalmann Financial Services reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Ladenburg Thalmann Financial Services sold 2,866 Alder Biopharmaceuticals shares in Q4 2019, an estimated $54K.
- Ladenburg Thalmann Financial Services first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 22 quarters.
- Ladenburg Thalmann Financial Services's Alder Biopharmaceuticals position peaked at $225K in Q4 2014.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.